Pain relief with Action Potential Simulation (APS) therapy
-
Upload
miranda-olding -
Category
Health & Medicine
-
view
242 -
download
3
Transcript of Pain relief with Action Potential Simulation (APS) therapy
Workshop overview Morning What is APS Therapy? History of APS APS in the UK, Personal history with APS How does it work? Action potentials & neuro-
hormonal effects Have a look Research on APS Our patients experiences & research at the MS
Centre Service/practice models
Workshop afternoon
Running a clinic Assessment, contra-indications & consent Outcome measures, research & documentation Treat each other Injury and inflammation Creating treatment plans Troubleshooting
What is APS Therapy Action Potential Simulation Safe, effective, drug free pain
relief Microcurrent electricity APS Therapy machine
History Developed in early 1990s, south Africa First machine treated shattered elbows
successfully Prof Christian Barnard used for arthritis to keep
working 1993 1st serial machine – MD in USA 1994 FDA approval 1998 CE approval ( Europe) 1998 Gold award Geneva Medical International
Invention Marketed without training in SA & UK Moved to Holland, model of training & therapists
My story with APS MS Nurse Background in holistic health, diet, nutrition,
seeking PWMS have a lot of pain Neuropathic & nociceptive Medications like anti-epileptics = fatigue, weight
gain More activity = more pain Lead to cycle of deconditioning & disability Hull – case studies – research – training Bedford – clinic - pilot study – results distributorship
Painfree Potential Aim To help people relieve their pain To train healthcare practitioners Raise awareness To stimulate research For APS Therapy to take its place as a validated
treatment for pain relief, available on the NHS.
Action Potentials The change in electrical potential
associated with the passage of an impulse along the membrane of a muscle cell or nerve cell’
All the processes of the body take place by the different types of specialised cells working in harmony with each other.
‘Action potentials’ facilitate waves of electrical communication between the cells.
Action potentials
A series of biochemical reactions take place, lasting just thousandths of a second
Electrically charged molecules of sodium or potassium rush in and out of cells, as ‘gates’ in the cell membranes open and close
When they get to certain concentrations, they trigger a electrical impulse, a ‘firing’ and a depolarisation,
sending a wave of information along to the next cell, and setting up for the next wave of action potential.
Action Potentials occur in nerve cells, muscles cells and endocrine
cells ‘nerve impulses’ or as the cell ‘firing’.
In neurons, they play a central role in cell-to-cell communication.
In other types of cells, their main function is to activate intracellular processes.
In muscle cells, for example, an action potential is the first step in the chain of events leading to contraction.
Boosting action potentials
Communication between cells is enhanced Enhanced removal of waste products Boosts production of ATP = speeds injury repair &
body’s own healing mechanisms Cellular repair and regeneration enhanced Faster wound and injury healing Improved recovery time after exercise Pain relief Better quality of sleep Enhanced energy
ATP storage and distribution vehicles of energy
adenosine, ribose, and three molecules of phosphate.
Energy is released when the phosphate bond is broken.
Function: convert glucose, from food, into energy. more ATP = better function and more energy
Decline in ATP production
lack of available nutrients, particularly oxygen and hydrogen, needed to create ATP.
free radicals created by chemicals in food and pollution,
poor dietary and lifestyle habits, weakened digestion leading to the inability to
break down nutrients from food, disease processes, including those that damage
the mitochondria. some people, eg athletes, place enormous
demands on the ATP in their systems.
Other Neuro-hormonal effects
Melatonin: significantly raised sedative, anxiolytic,local vasodilation & anticoagulation, limitation of tissue damage at sites of inflammation due to the effects on prostaglandins and free oxygen radicals.
Leukine enkephalin: progressively increased Effective analgesic due to interaction with opioid receptors as well
as inhibition of substance P (the neurotransmitter responsible for pain transmission). • Limitation of tissue damage at sites of inflammation and/or hypoxia. • Increase in pulse rate and systemic blood pressure, associated with peripheral vasodilation, which results in better perfusion at the affected areas. -
Neuro-hormonal Beta-endorphins: significantly decreased Cortisol: unchanged but uninhibited
Neurohormonal Consequences of APS TherapyProf. Dr. J.M.C. Oosthuizen MBCHB; DMEDSCI University of the Free State;Prof. Dr. E.H. de Wet MBCHB; MMED; MD
Electrotherapies One of 3 main physiotherapy modalities; manual
therapy, exercise therapy, electrotherapy. Electrical stimulation agents, including
Transcutaneous Electrical Nerve stimulation (TENS), Interferential Therapy (IFT), Functional Electrical Stimulation (FES), and Microcurrent therapy (MCT), Action Potential Simulation Therapy (APS Therapy)
Thermal modalities, including Infra red Irradiation (IFR), Therapeutic Ultrasound and Laser Therapy, and
Non Thermal Modalities including Pulsed Ultrasound, Pulsed Electromagnetic Fields (PEMFs) and Microcurrent Therapy (MCT)
Comparison + TENS
TENSAlternating currentForeign pulseGate theory pain reliefEndorphin on ‘tapping’ mode
APS TherapyDirect currentBiological frequenciesStimulating ATP, detox, injury repair Benefits accrue and are more lasting
Research in APS An assessment of APS Therapy on 285 Patients with Chronic Pain in
2002 reported a mean average VAPS was 6.8 before treatment and 3.3 after treatment in the over 50s, and 6.3 and 2.2 respectively in the under 50s. Out of the 285 patients,44 (15%) ended with a ‘0’ VAPS and 199 (69%) with a score of 5 or less. (1)
A trial of APS Therapy in patients awaiting or having neurosurgery for intractable spinal pain concluded that the number of patients treated was too low to reach a statistical conclusion, but that the trend was very promising and they recommended that patients waiting for destructive surgery should first be put on a thorough trial of APS Therapy.(2)
In a 1999 randomized, patient blinded, placebo-controlled study, on 76 patients with chronic osteoporotic back pain, reported pretreatment baseline VAPS value average of of 57.79, and post- treatment value after the sixth treatment of 9.7 (p= 0,0001); 6 patients maintained benefits 6 months post treatment.(3)
A study in 1999 on APS Therapy compared with TENS in 99 patients with osteoarthritis of the knee did not find a significant difference between the two treatment groups given just 6 treatments over a 2 week period. The authors did note, however, that the APS group showed a significant improvement in measures of knee flexion and swelling, which persisted even 1 month after the last treatment. (4)
References 1) Papendorp DH van. (2002). Assessment of Pain
Relief on 285 patients with chronic pain. Biomedical Research 2002; 26: 249-253.
2) Du Preez, J. Neurosurgical Pain Conditions University of Pretoria
3) Odendaal & Joubert APS Therapy- a new way of teating chronic backabacke, a pilot study South African Journal of Anaesthesiology and Analgesia.1999; 5 1
4) Berger, P. Matzner, L Study on 99 patients with osteoarthritis (OA) of the knee to investigate the effectiveness of low frequency electrical currents on mobility and pain: Action Potential Simulation therapy (APS) current compared with transcutaneous electrical nerve stimulation (TENS) and placebo.South Africa Journal of Anaesthesiology and Analgesia
Clinic APS machine Clinic – mark 1.4
• APS Therapy machine• Plastic carry case• Cords• Battery (9V, non rechargable)• Manual• Applicator• Gel• Sponge electrodes• Bathsalt• Earclips• PALS electrodes
Technical dataGENERAL
Number of outlets 4 (2 x black, 2 x red)
Operation 1 x intensity knob 1 x pulsed / continuous switch
Display 3 digit LCD which indicates milli amps.
Housing Aluminium / Plastic
POWER SUPPLY
Source Internal
Description 9V Alkaline or NIMH (rechargable) (use of rechargable battery is allowed, not standard included)
Type Pp3, 6LG61, 6AM6, Mn1604
ELECTRICAL
Wavetype Actie Potential (AP)
Pulse load 20 μCoulomb max
Pulse energy 220 mJoule max
Signal Continuous / Pulsating
Variable outlet – Charge – Current – Frequency 0 – 46 V (no load) 0 – 3,1 mA ± 0,3mA (1kΩ) 150 Hz ± 10%
TECHNICAL APPROVAL
CE 0482 Certificate of medical equipment. (Notified body: Medcert Hamburg, D) MDD93/42/EEC ANNEX IX (Class IIa / Rule 9)
ISO 9001 Quality control
DIN/ISO13485 Quality medical equipment
Jackie after 4 weeks Before I started the treatment I had the ‘MS hug’ really
badly. Most of the time the pain score was 5/10, but at times it was 11/ 10! Since I started the APS Therapy I haven’t had the really bad pain at all and most of the time the pain score is around 3.5/10, too low to notice. I also had knee pain, which was about 4.5/10 on the pain scale, and 7/10 when bad. Again, since having this treatment I haven’t had the bad pain at all and the pain score has gone down to around 3/10. The fact that I no longer notice pain shows the improvement. It’s just so nice not to have to constantly think about pain.
This treatment has also had a real impact on my sleep and fatigue. I usually wake up four or five times a night with pain, but last week I only woke once. Also, I don’t have that overwhelming feeling of tiredness. Last week I did so much! I took my brother… on holiday, which involved so much walking. Normally, I would have been exhausted, but I just wasn’t. My numbness is less noticeable too.” Jackie Clarke, Luton
Poppy ““I’ve not felt like this since I was about 15! For
two thirds of my life, I’ve been in some kind of pain, with lack of energy, not sleeping properly, having to plan essential things that I need to do, and then struggling to get them done, and frequently cancelling appointments because I’ve not been well enough to make them. Now, it’s my fourth week, and I’ve been active every day for the past 2 weeks. For instance, 3 weeks ago, my mum came to visit, and we walked everywhere, and then I had to spend Monday in bed. 2 weeks ago, a friend came to visit, we did the same walking, but the next day I was just up and active at 6/7 am. Now I’m sleeping well at night, and nothing is such an effort any more. I want to bottle it and give it to everyone I know!”
‘Action Potential Simulation Therapy ( APS Therapy) for pain in people with MS; Report on a one year
pilot study ‘
Findings: 2013 42 people began the course 6 dropped out 1 x Migraine 1 x Vomiting 1 x Discouragement after 2 weeks 1 x Visual disturbance 2 x Ill with pre-existing medical condition
‘Improvement’
Counted as 1 whole point on the VAS
Average improvement overall was 4.7 points
12 people reduced or discontinued medication
Could have been more, hadn’t planned
The remaining pains were:
2 x muscle fatigue type pain – no result 1 x post pin and plate – no result
1 x psoriasis pain – good result1 x varicose vein pain – good result
Other benefits attributed include:
Increase in energy, reduction in fatigue x 4 Reduction in swollen legs & ankles x 2 Alleviation of life-long insomnia x 2 Cessation of recurrent UTIs x 2 Improvement in circulation & discolouration Reduction of ‘fatty lump’ on hip Disappearance of swollen glands on neck Cessation of ‘fluid on skull’ sensation Reduction in dizziness & improved cognitive
function
Resources APS Machines, Electrodes, water electrodes Chair Surface Alcohol gel & tissues or wipes, bin Mirror can be helpful Blanket, Screens Files to store treatment plans & electrodes Space for carer / assistant / wheelchair Instruction posters For water treatment: bathsalts, somewhere to fill
bowls, ? Store bowls & towels – or get to bring in.
Patient’s journey at MSTC
Eight week course, outcomes: Cure/ no result/ Benefit, wants long term continuation, able to
reduce/ Purchase own machine MS Nurse –assesses, screens, oversees APS Therapist – timetables, trains patient/carer,
creates treatment plan, assesses, reviews & assists
Volunteers – assist clients, carry out regular review
Patient/members mainly self-manage
Difficulties along the way
Side effects? Detox effects 1 x brief exacerbation of pain ? Visual flickering reported x 1 Long term use – management problem Attributing problems Individuals
Models Clinic service, free at point of delivery Paying clinic service Rental for home use Mobile or private therapist
Discussion www.painfreepotential.co.uk 01908 799870 [email protected] Beds & Northants MS Therapy Centre www.APSTherapy.com is HQ in Holland
Thankyou very much